France Archives

News and Trends 7 Jan 2016

3 French Bioentrepreneurs are Awarded for Being Stubborn

Building a company is extremely difficult and obstination is sometimes needed to reach success. The organisation, France Biotech, has given a price to the founder of Innate-Pharma, OSE Pharma and Effimune for their respective success. Why? From left to right, Hervé Brailly, CEO & Founder of Innate-Pharma, Denis Lucquin, Managing Director of Sofinnova Partners, Maryvonne Hiance, […]

January 7, 2016 - 3 minutesmins - By Philip Hemme

embl microbiome janssen eligo enterome jj inra therapeutics crohns

News and Trends 7 Jan 2016

Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute

The Janssen Human Microbiome Institute, the French National Institute for Agricultural Research (INRA) and Johnson & Johnson Innovation AND Takeda are signing up to collaborate with the Paris biotech Enterome to help accelerate Microbiomics research into Crohn’s Disease. The collaboration is based on initial findings by the INRA showing that some commensal (symbiotic) bacteria elicit […]

January 7, 2016 - 3 minutesmins - By Dani Bancroft

audi global bioenergies biofuels car isobutene

News and Trends 6 Jan 2016

Audi Strengthens Collaboration with French Biotech for the Future of Automotive Biofuels

Audi is entering a renewed collaboration agreement with French Global Bioenergies to further broaden the flexibility of their biofuels technology for Greener Cars. The Paris based Global Bioenergies approach to second-generation isobutene production (using non-edible sources of biomass – e.g. wood chips) has turned out to be hugely popular, earning a €1.4M investment back in […]

January 6, 2016 - 2 minutesmins - By Dani Bancroft

nanomedicine nanoxray nanobiotix prostatecancer trials

News and Trends 4 Jan 2016

French Nano-Xrays to Kill Prostate Cancer in Phase I/II Trial

A Parisian Nanomedicine biotech is using it’s proprietary NanoXray technology to enhance radiotherapy. Now a candidate to treat Prostate cancer has received FDA approval for a phase I/II trial in the US. Nanobiotix is seeking to develop NBTXR3 for patients with intermediate and high-risk prostate cancer, with the aim of providing effective tumor destruction and […]

January 4, 2016 - 3 minutesmins - By Dani Bancroft

leukemia ucart19 cellectis cancer cart trial UK

News and Trends 4 Jan 2016

Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK

So it begins…dubbed the ‘Miracle Cure’ for Blood Cancer, UCART19 is now set to begin its journey to Human trials in the UK. Just 2 days before Christmas, the French billion euro Biotech, Cellectis, submitted a clinical trial application to the Medicines & Healthcare products Regulatory Agency (MHRA). Specifically, the request was to approve initiation […]

January 4, 2016 - 2 minutesmins - By Dani Bancroft

aging regenerative medicine genetics genome longevity

News and Trends 4 Jan 2016

Genomics’ Holy Grail: The Secret to Super-Longevity Lies in your Genes

The search for the Holy Grail in aging has long been a focus in regenerative medicine, which poses the question: why do some of us age better than others? Now growing evidence in Genomic Studies shows that there are key genetic players in the Aging game… Ever since the Human Genome Project, which began 25 […]

January 4, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 31 Dec 2015

Did you Know the Biotech Processes behind Wine and Champagne?

Besides bread based confections, making alcohol from fruit is one of the oldest biotech processes. But what is really behind the transformation of grapes into wonderful wines, or even champagne? Colorful beverages As we are talking about biotechnology, it is crucial to discuss the micro-organisms involved in the process. But I think you would also love to […]

December 31, 2015 - 4 minutesmins - By Jerome Topsent

ovarian cancer gamamabs antibodies bpifrance rothschild

News and Trends 16 Dec 2015

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

GamaMabs from France (Paris & Toulouse) has secured a €15M Series B Fundraising round for its Antibody targeting Gynecological cancers. GamaMabs Pharma is a French biotechnology company developing innovative monoclonal antibodies in cancer. GamaMabs’ lead project is the monoclonal antibody (mAb) GM102 (formerly known as 3C23K), and they have previously partnered with Curie Cancer Institute […]

December 16, 2015 - 2 minutesmins - By Dani Bancroft

ngs bioinformatics biomerieux illumina microbiology immunoassay

News and Trends 16 Dec 2015

Global NGS Leader’s Influence in European Bioinformatics Field is Spreading Interest in Microbiomics

BioMérieux (France) is a diagnostics tech company which has partnered with the US Bioinformatics Giant Illumina to produce a novel Microbiological genetics sequencing kit: the bioMérieux EpiSeq. BioMérieux is a worldwide leading provider of diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and reduce risk of hospital […]

December 16, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 14 Dec 2015

World’s First Microbiome Fund Swells to €160M With Major Pharma Also Chipping In

The French VC firm Seventure‘s Health for Life Capital investment fund for Microbiome and Biotech has had an additional €60M pumped into it by Swiss Pharma Giant Novartis and other investors. Health for Life Capital is the first and unique microbiome focused investment vehicle. Now it has been announced that Novartis and other investors have also become […]

December 14, 2015 - 2 minutesmins - By Dani Bancroft

blood cells transport drugs rubius therapeutics flagship erytech pku

News and Trends 14 Dec 2015

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

Erytech (France) is working on a drug-transportation system using red blood cells. Now US Rubius Therapeutics joins Erytech on this new approach to drug delivery, backed by the huge VC in the States; Flagship Ventures. Flagship Ventures has yet again shown its comprehensive portfolio in biotech through another EU inspired Biotech start-up. Rubius Therapeutics in […]

December 14, 2015 - 3 minutesmins - By Dani Bancroft

dbv technologies viaskin peanuts allergy e1457626501488

News and Trends 10 Dec 2015

Peanut Allergies? This Phase III Trial Could Mean an End to Nut-Related Anaphylaxis

Peanut allergy in children can be life-threatening, with safe treatment options available. Now DBV Technologies in Paris has a phase III transdermal patch which desensitizes the patient to peanuts, with fast-track FDA approval. The allergens in peanuts can stimulate an immune response to their presence, which can even result in life-threatening anaphylaxis (here is a […]

December 10, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

3 French Bioentrepreneurs are Awarded for Being Stubborn

Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute

Audi Strengthens Collaboration with French Biotech for the Future of Automotive Biofuels

French Nano-Xrays to Kill Prostate Cancer in Phase I/II Trial

Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK

Genomics’ Holy Grail: The Secret to Super-Longevity Lies in your Genes

Did you Know the Biotech Processes behind Wine and Champagne?

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

Global NGS Leader’s Influence in European Bioinformatics Field is Spreading Interest in Microbiomics

World’s First Microbiome Fund Swells to €160M With Major Pharma Also Chipping In

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

Peanut Allergies? This Phase III Trial Could Mean an End to Nut-Related Anaphylaxis

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!